Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Boehringer Ingelheim
Harvard Business School
Moodys
Colorcon

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Valeant Pharm Intl Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for VALEANT PHARM INTL, and what generic and branded alternatives to VALEANT PHARM INTL drugs are available?

VALEANT PHARM INTL has forty-one approved drugs.



Summary for Valeant Pharm Intl
US Patents:0
Tradenames:34
Ingredients:29
NDAs:41

Drugs and US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 AN RX Yes Yes   Start Trial   Start Trial
Valeant Pharm Intl LIBRITABS chlordiazepoxide TABLET;ORAL 085488-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Valeant Pharm Intl TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060471-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Valeant Pharm Intl LIBRIUM chlordiazepoxide hydrochloride CAPSULE;ORAL 012249-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 4,797,405   Start Trial
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-002 Dec 30, 1988 4,797,405   Start Trial
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-001 Dec 30, 1988 4,166,182   Start Trial
Valeant Pharm Intl LIBRELEASE chlordiazepoxide CAPSULE, EXTENDED RELEASE;ORAL 017813-001 Sep 12, 1983 4,316,897   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for VALEANT PHARM INTL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Inhalation Solution 6 gm/vial ➤ Subscribe 2014-05-22
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKesson
Boehringer Ingelheim
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.